MANAGEMENT CONSULTING PHARMA
Board
1 director, since incorporationDirector (not named in the articles)
appointed by deed of 28-06-2024
term without a fixed end
listed in the 2025 annual accounts, filed on 04-12-2025
- Signing authorityThe articles say who may bind the company, for example by signing a contract.
- “B/ Pouvoirs Chaque administrateur agissant seul représente la société à l'égard des tiers et en justice, soit en demandant, soit en…”deed of 28-06-2024
Mandates through the years
1 name, the dashed line is todayDirector (not named in the articles)
Board
Mandates as a list
-
- Director (not named in the articles), appointed by deed of 28-06-2024, still in office
Control
Founder
This company
MANAGEMENT CONSULTING PHARMA
Equity €105,238
Profit €101,238 in 2025
Capital
- Contribution
- €4,000
- Shares
- 100
- Contribution per share
- €40
- Equity per share
- €1,052 in 2025
- Source
- 2025 annual accounts
Articles of association
deed of 28-06-2024 (in French)- DurationMost companies exist for an unlimited period, until they are dissolved.
- Unlimited
- Board ruleThese rules set how the board is made up, meets and takes decisions.
- “Frais representation voyages deplacements en sus, Article13”
Founder
At incorporation
deed of 28-06-2024 ↗
- sole founder · 100% at incorporation